Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Versus Conventional Intensity-Modulated Radiation Therapy for Breast Cancer Patients With an Indication for Regional Nodal Irradiation: A Randomized Multi-center Phase III Trial

NCT03829553 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT03829553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Versus Conventional Intensity-Modulated Radiation Therapy for Breast Cancer Patients With an Indication for Regional Nodal Irradiation: A Randomized Multi-center Phase III Trial
Lead sponsor
Ruijin Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
February 21, 2019
Completion date
December 31, 2027
Enrollment
801 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer